SAN

102.74

-0.04%↓

SHL.DE

50.02

-0.68%↓

ARGX

544.8

+0.41%↑

FRE

39.56

+0.48%↑

PHIA

23.63

+1.33%↑

SAN

102.74

-0.04%↓

SHL.DE

50.02

-0.68%↓

ARGX

544.8

+0.41%↑

FRE

39.56

+0.48%↑

PHIA

23.63

+1.33%↑

SAN

102.74

-0.04%↓

SHL.DE

50.02

-0.68%↓

ARGX

544.8

+0.41%↑

FRE

39.56

+0.48%↑

PHIA

23.63

+1.33%↑

SAN

102.74

-0.04%↓

SHL.DE

50.02

-0.68%↓

ARGX

544.8

+0.41%↑

FRE

39.56

+0.48%↑

PHIA

23.63

+1.33%↑

SAN

102.74

-0.04%↓

SHL.DE

50.02

-0.68%↓

ARGX

544.8

+0.41%↑

FRE

39.56

+0.48%↑

PHIA

23.63

+1.33%↑

Search

EssilorLuxottica SA

Open

BrancheGesundheitswesen

267.8 0.22

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

262.6

Max

268.7

Schlüsselkennzahlen

By Trading Economics

Einkommen

-371M

994M

Verkäufe

-72M

13B

KGV

Branchendurchschnitt

52.729

73.239

EPS

2.976

Dividendenrendite

1.48

Gewinnspanne

7.52

Angestellte

153,498

EBITDA

635M

3.6B

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+8.1% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.48%

3.06%

Nächstes Ergebnis

17. Apr. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

2.3B

124B

Vorheriger Eröffnungskurs

267.58

Vorheriger Schlusskurs

267.8

Nachrichtenstimmung

By Acuity

58%

42%

313 / 386 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

EssilorLuxottica SA Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

12. Feb. 2025, 18:35 UTC

Ergebnisse

Ray-Ban Maker EssilorLuxottica Logs Higher Sales Amid North America, China Growth -- Update

12. Feb. 2025, 17:32 UTC

Ergebnisse

Ray-Ban Maker EssilorLuxottica Posts Higher Profit on Sales Growth

2. Jan. 2025, 17:29 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica Buys AI Startup in Hearing Market Push

28. März 2025, 08:57 UTC

Market Talk

EssilorLuxottica Should Be Able to Cope With U.S. Volatility -- Market Talk

13. Feb. 2025, 11:05 UTC

Market Talk
Ergebnisse

EssilorLuxottica Seems Poised to Ride the Technology Wave -- Market Talk

13. Feb. 2025, 10:54 UTC

Market Talk
Ergebnisse

EssilorLuxottica's Midterm Margin Target Seems Challenging -- Market Talk

13. Feb. 2025, 08:41 UTC

Market Talk
Ergebnisse

EssilorLuxottica's Sales Are Better Than Expected -- Market Talk

12. Feb. 2025, 17:05 UTC

Ergebnisse

EssilorLuxottica Backs Mid-Term Targets

12. Feb. 2025, 17:05 UTC

Ergebnisse

EssilorLuxottica 2024 Oper Pft EUR3.45B

12. Feb. 2025, 17:04 UTC

Ergebnisse

Analysts Had Seen EssilorLuxottica 2024 Net Pft at EUR2.50B

12. Feb. 2025, 17:04 UTC

Ergebnisse

EssilorLuxottica 2024 Net Pft EUR2.36B

12. Feb. 2025, 17:03 UTC

Ergebnisse

EssilorLuxottica 2024 Rev EUR26.51B

12. Feb. 2025, 17:03 UTC

Ergebnisse

EssilorLuxottica 4Q Rev EUR6.78B

12. Feb. 2025, 17:01 UTC

Ergebnisse

Analysts Had Seen EssilorLuxottica 4Q Rev at EUR6.68B

12. Feb. 2025, 17:00 UTC

Ergebnisse

EssilorLuxottica Declares Dividend of EUR3.95 a share

11. Feb. 2025, 16:30 UTC

Market Talk

EssilorLuxottica Has Bright Future Ahead Amid Smart Glasses Push -- Market Talk

11. Feb. 2025, 10:58 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica Continues Ophthalmology Expansion With Cellview Acquisition -- Market Talk

11. Feb. 2025, 07:03 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica Doesn't Disclose Financial Details

11. Feb. 2025, 07:03 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica Aims to Build Wider Portfolio of Ophthalmic Instruments, Services With Deal

11. Feb. 2025, 07:02 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica: Toronto-Based Cellview Specializes in Diagnostic via Retinal Imaging

11. Feb. 2025, 07:01 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottic Acquires Canadian Med-Tech Startup Cellview

11. Feb. 2025, 07:00 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica to Buy Cellview

2. Jan. 2025, 17:04 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica Didn't Disclose Financial Details

2. Jan. 2025, 17:03 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica: This Allows People With Hearing Impairment to Better Understand Speech

2. Jan. 2025, 17:02 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica: Pulse Audition Delivers AI-based Noise Reduction, Voice Enhancement

2. Jan. 2025, 17:01 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica Acquires Pulse Audition

2. Jan. 2025, 17:00 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica Strengthens Its Presence in Hearing Space With Acquisition of AI-driven Tech Startup in France

3. Dez. 2024, 16:21 UTC

Market Talk

EssilorLuxottica Could Be Hit by U.S. Tariffs -- Market Talk

6. Nov. 2024, 09:01 UTC

Market Talk

European Luxury Stocks Get Boost From Trump Potential Win -- Market Talk

18. Okt. 2024, 07:08 UTC

Market Talk
Ergebnisse

EssilorLuxottica Tries Soothe Nerves After Revenue Misses Forecasts -- Market Talk

Peer-Vergleich

Kursveränderung

EssilorLuxottica SA Prognose

Kursziel

By TipRanks

8.1% Vorteil

12-Monats-Prognose

Durchschnitt 288.2 EUR  8.1%

Hoch 335 EUR

Tief 245 EUR

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für EssilorLuxottica SA – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

11 ratings

7

Buy

4

Halten

0

Sell

Technischer Score

By Trading Central

263.6 / 265.8Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

Strong Bearish Evidence

Langfristig

No Evidence

Stimmung

By Acuity

313 / 386 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über EssilorLuxottica SA

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands. It also provides finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the Essilor Instruments brand; high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. In addition, the company provides eyewear products under the Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native, Luxottica, Sferoflex, Bolon, Molsion, DbyD, and Unofficial and Seen, as well as other Licensed brands. In addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.